Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

C4 Therapeutics (CCCC) Net Cash Flow (2019 - 2026)

C4 Therapeutics has reported Net Cash Flow over the past 8 years, most recently at -$13.3 million for Q1 2026.

  • For Q1 2026, Net Cash Flow fell 216.9% year-over-year to -$13.3 million; the TTM value through Mar 2026 reached $10.0 million, up 126.02%, while the annual FY2025 figure was $19.1 million, 126.87% up from the prior year.
  • Net Cash Flow for Q1 2026 was -$13.3 million at C4 Therapeutics, down from $15.8 million in the prior quarter.
  • Over five years, Net Cash Flow peaked at $65.6 million in Q4 2023 and troughed at -$36.9 million in Q1 2024.
  • A 5-year average of -$863882.4 and a median of -$4.6 million in 2023 define the central range for Net Cash Flow.
  • Biggest five-year swings in Net Cash Flow: tumbled 287.26% in 2024 and later skyrocketed 480.58% in 2025.
  • Year by year, Net Cash Flow stood at -$19.8 million in 2022, then soared by 431.4% to $65.6 million in 2023, then plummeted by 106.33% to -$4.1 million in 2024, then skyrocketed by 480.58% to $15.8 million in 2025, then tumbled by 184.39% to -$13.3 million in 2026.
  • Business Quant data shows Net Cash Flow for CCCC at -$13.3 million in Q1 2026, $15.8 million in Q4 2025, and -$19.3 million in Q3 2025.